Supplemental information

9 Months Ended

May 31, 2021

Supplemental Cash Flow Elements [Abstract]

Supplemental information

Supplemental information

Accounts receivable

Accounts receivable are stated net of allowances for doubtful accounts. Accounts receivable balances primarily consist of trade receivables due from customers, including amounts due from third party providers (e.g., pharmacy benefit managers, insurance companies and governmental agencies). Trade receivables were $3.9 billion and $3.0 billion at May 31, 2021 and August 31, 2020, respectively. Other accounts receivable balances, which consist primarily of receivables from vendors and manufacturers, including receivables from AmerisourceBergen (see Note 17 Related parties), were $1.3 billion and $1.1 billion at May 31, 2021 and August 31, 2020, respectively.

Depreciation and amortization

The Company has recorded the following depreciation and amortization expense in the Consolidated Condensed Statements of Earnings (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2021		2020		2021		2020
Depreciation expense	$	352	$	349	$	1,042	$	1,051
Intangible asset and other amortization	156		93		363		290
Total depreciation and amortization expense	$	507	$	443	$	1,404	$	1,341

Accumulated depreciation and amortization on property, plant and equipment was $13.0 billion at May 31, 2021 and $12.1 billion at August 31, 2020.

Restricted cash

The Company is required to maintain cash deposits with certain banks which consist of deposits restricted under contractual agency agreements and cash restricted by law and other obligations.

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of May 31, 2021 and August 31, 2020 (in millions):

	May 31, 2021		August 31, 2020
Cash and cash equivalents - continuing operations	$	1,345	$	469
Cash and cash equivalents - discontinued operations	239		47
Restricted cash - continuing operations (included in other current assets)	76		62
Restricted cash - discontinued operations	143		168
Cash, cash equivalents and restricted cash	$	1,803	$	746

Redeemable noncontrolling interest

The redeemable noncontrolling interest balance as of May 31, 2021 was $310 million due to acquisitions during the nine months period ended May 31, 2021. See Note 3 Acquisitions for further details.

Earnings per share

The dilutive effect of outstanding stock options on earnings per share is calculated using the treasury stock method. Stock options are anti-dilutive and excluded from the earnings per share calculation if the exercise price exceeds the average market price of the common shares. There were 15.9 million weighted outstanding options to purchase common shares that were anti-dilutive and excluded from the third quarter earnings per share calculation as of May 31, 2021 compared to 20.5 million as of May 31, 2020.

Due to the anti-dilutive effect resulting from the reported net loss during three months and nine months ended May 31, 2020, the incremental impact of potentially dilutive securities were omitted from the calculation of weighted-average common shares outstanding.

Cash dividends declared per common share

Cash dividends per common share declared were as follows:

Quarter ended	2021		2020
November	$	0.4675	$	0.4575
February	$	0.4675	$	0.4575
May	$	0.4675	$	0.4575
	$	1.4025	$	1.3725